When iGaming operators contribute money to gambling harm research, they are often accused of bias. When they do not contribute, they are accused of indifference. This funding paradox sits at the heart of one of the most unresolved debates in responsible gambling policy, and it carries real operational consequences for licensed operators.
The Core Tension in Research Funding
Independent scientific research costs money. In the gambling sector, that money has to come from somewhere, and the two most obvious sources are public taxation revenues and the industry itself. Both routes attract criticism. Public funding is limited and politically unpredictable. Industry funding is abundant but carries an inherent perception problem: can research sponsored by the very companies that profit from gambling ever be considered genuinely independent?
Critics argue that industry-funded studies, even when conducted by credible academics, face structural pressures that tilt findings toward conclusions convenient for operators. Researchers may self-censor topics, funders may retain influence over publication, and the overall research agenda may drift away from the questions most likely to produce uncomfortable answers. This is not a problem unique to gambling. Similar debates have played out in pharmaceutical research and the food industry for decades.
Why Operators Cannot Simply Opt Out
The straightforward response for an operator wishing to avoid reputational risk might be to stop funding research entirely. In practice, this option is rarely available. Regulatory frameworks in multiple jurisdictions either mandate financial contributions to harm-reduction funds or use participation in such schemes as a licensing criterion. Operators in the UK, for instance, have operated under expectations tied to the Gambling Commission's requirements, and similar obligations exist or are emerging across regulated European markets.
Beyond legal obligation, stepping back from funding creates its own narrative problem. An operator that declines to support harm research is quickly characterised as unconcerned with player welfare, which is damaging in an era where responsible gambling credentials influence both regulatory relationships and player trust.
Structural Safeguards That Can Help
The most defensible position for operators is not to avoid funding research but to insist on governance structures that genuinely separate commercial interests from scientific process. Several mechanisms have been proposed or tested across different markets:
- Independent research committees with no operator representatives in decision-making roles
- Pre-registered study protocols published before data collection begins, preventing post-hoc manipulation of findings
- Open-access publication requirements so results cannot be quietly shelved
- Pooled industry levies administered by a statutory or arms-length body rather than individual companies
- Transparent disclosure of all funding sources in every published paper
None of these mechanisms is perfect, but collectively they raise the credibility threshold considerably. Operators who actively advocate for these safeguards, rather than simply writing cheques, are in a meaningfully stronger position when their funding practices come under scrutiny.
Implications for Compliance and Brand Reputation
For compliance officers, the funding debate is not abstract. Regulators increasingly scrutinise how operators demonstrate commitment to player protection, and the quality and independence of research they support is part of that picture. An operator linked to research later discredited as commercially influenced faces questions not just about the research but about its broader compliance culture.
For brand owners and marketing teams, the reputational dimension is equally significant. Players and advocacy groups pay attention to how operators engage with harm-reduction agendas. A credible, well-governed research contribution is a stronger signal of genuine commitment than corporate responsibility statements alone.
Operators who fund research with robust independence safeguards convert a potential liability into a demonstrable compliance asset, provided the governance structures are transparent and consistently applied.
The OnlineShine Perspective
At OnlineShine, we advise operator clients to treat research funding as a compliance and reputation matter requiring the same rigour as AML controls or player verification processes. That means documenting governance arrangements, retaining evidence of arm's-length decision-making, and ensuring that any funded research meets publication and pre-registration standards. The goal is not to escape criticism entirely, which is probably impossible, but to ensure that the criticism is demonstrably unfounded when it arrives.
